Hartley O - Search Results

1

Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes.

Dorgham K, Dogan I, Bitton N, Parizot C, Cardona V, Debré P, Hartley O, Gorochov G. Dorgham K, et al. Among authors: hartley o. AIDS Res Hum Retroviruses. 2005 Jan;21(1):82-92. doi: 10.1089/aid.2005.21.82. AIDS Res Hum Retroviruses. 2005. PMID: 15665647

2

Engineered CCR5 superagonist chemokine as adjuvant in anti-tumor DNA vaccination.

Dorgham K, Abadie V, Iga M, Hartley O, Gorochov G, Combadière B. Dorgham K, et al. Among authors: hartley o. Vaccine. 2008 Jun 19;26(26):3252-60. doi: 10.1016/j.vaccine.2008.04.003. Epub 2008 Apr 24. Vaccine. 2008. PMID: 18479788

3

Generating Chemokine Analogs with Enhanced Pharmacological Properties Using Phage Display.

Dorgham K, Cerini F, Gaertner H, Melotti A, Rossitto-Borlat I, Gorochov G, Hartley O. Dorgham K, et al. Among authors: hartley o. Methods Enzymol. 2016;570:47-72. doi: 10.1016/bs.mie.2015.09.014. Epub 2015 Nov 14. Methods Enzymol. 2016. PMID: 26921941

4

Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.

Hartley O, Dorgham K, Perez-Bercoff D, Cerini F, Heimann A, Gaertner H, Offord RE, Pancino G, Debré P, Gorochov G. Hartley O, et al. J Virol. 2003 Jun;77(12):6637-44. doi: 10.1128/jvi.77.12.6637-6644.2003. J Virol. 2003. PMID: 12767983 Free PMC article.

5

An engineered CX3CR1 antagonist endowed with anti-inflammatory activity.

Dorgham K, Ghadiri A, Hermand P, Rodero M, Poupel L, Iga M, Hartley O, Gorochov G, Combadière C, Deterre P. Dorgham K, et al. Among authors: hartley o. J Leukoc Biol. 2009 Oct;86(4):903-11. doi: 10.1189/jlb.0308158. Epub 2009 Jul 1. J Leukoc Biol. 2009. PMID: 19571253

6

V3: HIV's switch-hitter.

Hartley O, Klasse PJ, Sattentau QJ, Moore JP. Hartley O, et al. AIDS Res Hum Retroviruses. 2005 Feb;21(2):171-89. doi: 10.1089/aid.2005.21.171. AIDS Res Hum Retroviruses. 2005. PMID: 15725757 Review.

7

Synthesis of cyclic peptides from unprotected precursors using removable N alpha-(1-(4-methoxyphenyl)-2-mercaptoethyl) auxiliary.

Cardona VM, Hartley O, Botti P. Cardona VM, et al. Among authors: hartley o. J Pept Res. 2003 Mar;61(3):152-7. doi: 10.1034/j.1399-3011.2003.00043.x. J Pept Res. 2003. PMID: 12558950

8

Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide.

Gaertner H, Cerini F, Escola JM, Kuenzi G, Melotti A, Offord R, Rossitto-Borlat I, Nedellec R, Salkowitz J, Gorochov G, Mosier D, Hartley O. Gaertner H, et al. Among authors: hartley o. Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17706-11. doi: 10.1073/pnas.0805098105. Epub 2008 Nov 12. Proc Natl Acad Sci U S A. 2008. PMID: 19004761 Free PMC article.

9

Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors.

Hartley O, Gaertner H, Wilken J, Thompson D, Fish R, Ramos A, Pastore C, Dufour B, Cerini F, Melotti A, Heveker N, Picard L, Alizon M, Mosier D, Kent S, Offord R. Hartley O, et al. Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16460-5. doi: 10.1073/pnas.0404802101. Epub 2004 Nov 15. Proc Natl Acad Sci U S A. 2004. PMID: 15545608 Free PMC article.

10

Engineering chemokines to develop optimized HIV inhibitors.

Hartley O, Offord RE. Hartley O, et al. Curr Protein Pept Sci. 2005 Jun;6(3):207-19. doi: 10.2174/1389203054065400. Curr Protein Pept Sci. 2005. PMID: 15974948 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page